ArticleThe ISME journal2018
Dissemination and persistence of extended-spectrum cephalosporin-resistance encoding IncI1-bla
Article in The ISME journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- Lineage-aware comparison of extended-spectrumMicrobial genomics · 2026Article
- High-resolution characterization of the temporal and spatial distribution of antimicrobial resistance in Escherichia coli from pigs.The Journal of antimicrobial chemotherapy · 2026Article
- Distribution and characteristics of ceftiofur-resistant Escherichia coli throughout the broiler production chain in Korea.Veterinary research · 2026Article
- Closely RelatedVeterinary sciences · 2026Article
- Complete genomic sequencing and characterization of an ESBL-producingmicroPublication biology · 2026Article
- Co-Occurrence and Molecular Characterization of ESBL-Producing and Colistin-ResistantFoods (Basel, Switzerland) · 2025Article
- Article
- Integration sites ofFrontiers in microbiology · 2025Article
- Article
- The Global Rise of ESBL-ProducingAnimals : an open access journal from MDPI · 2024Review
- Phylogenetics and Mobilization of Genomic Traits of Cephalosporin-ResistantPathogens (Basel, Switzerland) · 2024Article
- Isolation of a CTX-M-55 (ESBL)-Producing Escherichia coli Strain of the Global ST6448 Clone from a Captive Orangutan in the USA.Current microbiology · 2024Article
- Antimicrobial Resistance in CommensalAntibiotics (Basel, Switzerland) · 2023Review
- A global survey ofMicrobial genomics · 2023Article
- Development of an In Vivo Extended-Spectrum Cephalosporin-ResistantAnimals : an open access journal from MDPI · 2023Article
- Comparison of antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms with and without zinc oxide and antimicrobial usage.Gut pathogens · 2023Article
- The "Cins" of Our Fathers: Rejuvenated Interest in Colicins to Combat Drug Resistance.Journal of microbiology (Seoul, Korea) · 2023Review
- Phenotypic and Genotypic Analysis of Antimicrobial Resistance inAnimals : an open access journal from MDPI · 2022Article
- Prevalence and antimicrobial susceptibility of CTX-M-type-producing Escherichia coli from a wildlife zoo in China.Veterinary medicine and science · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the ecology, epidemiology and plasmid characteristics of extended-spectrum cephalosporin (ESC)-resistant E. coli in healthy pigs over a period of 4 years (2013-2016) following the withdrawal of ESCs. High carriage rates of ESC-resistant E. coli were demonstrated in 2013 (86.6%) and 2014 (83.3%), compared to 2015 (22%) and 2016 (8.5%). ESC resistance identified among E. coli isolates was attributed to the carriage of an IncI1 ST-3 plasmid (pCTXM1-MU2) encoding bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.